Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
900PD A Randomized Phase II Study of OGX-427 Plus...
Conference

900PD A Randomized Phase II Study of OGX-427 Plus Prednisone (P) Vs. P Alone in Patients (PTS) with Metastatic Castration Resistant Prostate Cancer (CRPC)

Abstract

Background Heat Shock Protein 27 (Hsp27) is a multi-functional chaperone that regulates cell signaling and survival pathways implicated in cancer progression. In prostate cancer models, Hsp27 chaperones androgen receptor (AR) and enhances transactivation of AR-regulated genes. OGX-427 is a 2nd generation antisense that inhibits Hsp27 expression with in vitro and in vivo efficacy and was well tolerated in phase I studies. Methods …

Authors

Chi K; Yu EY; Ellard S; Hotte SJ; Gingerich JR; Joshua AM; Gleave ME

Volume

23

Publisher

Elsevier

Publication Date

September 2012

DOI

10.1016/s0923-7534(20)33525-0

Conference proceedings

Annals of Oncology

ISSN

0923-7534